ETF Managers Group, LLC Adaptive Biotechnologies Corp Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, ETF Managers Group, LLC holds 44,598 shares of ADPT stock, worth $161,444. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,598

Previous 172,386 74.13%

Holding current value

$161,444

Previous $1.32 Million 70.16%

% of portfolio

0.01%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$7.8 - $10.11 $996,746 - $1.29 Million	-127,788 Reduced 74.13%	44,598 $393,000
Q4 2022 Mar 23, 2023	BUY	$6.26 - $9.34 $815,208 - $1.22 Million	130,225 Added 308.88%	172,386 $1.32 Million
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $18,031 - $35,146	-2,774 Reduced 6.17%	42,161 $300,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $12,723 - $29,283	1,988 Added 4.63%	44,935 $369,000
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $2,965 - $8,467	293 Added 0.69%	42,947 $596,000

Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $220,111 - $322,253	-8,745 Reduced 17.01%	42,654 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $300,620 - $399,258	10,014 Added 24.2%	51,399 $1.67 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $43,239 - $59,839	-1,342 Reduced 3.14%	41,385 $1.75 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $159,510 - $289,994	-4,281 Reduced 9.11%	42,727 $1.61 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $117,296 - $170,614	-2,606 Reduced 5.25%	47,008 $2.79 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $1.13 Million - $1.55 Million	31,659 Added 176.32%	49,614 $2.38 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $447,977 - $868,662	17,955 New	17,955 $827,000

Others Institutions Holding ADPT

# of Institutions

200

Shares Held

146M

Call Options Held

2.6K

Put Options Held

143K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $517M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Adaptive Biotechnologies Corp Transaction History